Publications by authors named "Yulong Mu"

Claim this Profile
C
circHMGCS1 Promotes the Progression of NSCLC by Regulating the HuR/SFPQ/TNF Pathway.
Jiayue An, Weimiao Sun, Chenhui Ti, Yulong Mu, Baohui Yin

FASEB J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between triglyceride-glucose index and activities of daily living disability among middle-aged and older patients with arthritis: longitudinal evidence from CHARLS.
Liang Ma, Yu-Long Mu, Zhuo-Ming Liu, Shu-Wei Jiang, De-Qiang Li

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global research trends in surgical management of choledochal cysts: a bibliometric analysis from 2000 to 2024.
Xingjian Liu, Guodong Zhu, Jiayi Zhang, Yulong Mu, Zongxing Qiao

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular subtyping of endometrial cancer via a simplified one-step NGS classifier, ARID1A and ZFHX4 mutations help further subclassify CNL/MSI-H patients.
Qiuli Teng, Zeng Yuan, Yulong Mu, Xinyue Ma, Shuaixin Wang

Diagn Pathol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and verification of a prognostic signature associated with fatty acid metabolism in endometrial cancer.
Lu Peng, Rui Sun, Tingting Hao, Yulong Mu, Qing Zhang

Mol Med Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
lncRNA KTN1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑505‑3p.
Yulong Mu, Qiang Tang, Haiyan Feng, Luwen Zhu, Yan Wang

Oncol Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1.
Piyun Sun, Yulong Mu, Shuyan Zhang

Tumour Biol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-106a is an independent prognostic marker in patients with glioblastoma.
Shiguang Zhao, Guang Yang, Yulong Mu, Dayong Han, Chen Shi

Neuro Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-153 is tumor suppressive in glioblastoma stem cells.
Shiguang Zhao, Yifan Deng, Yaohua Liu, Xin Chen, Guang Yang, Yulong Mu

Mol Biol Rep· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
Guang Yang, Ruyou Zhang, Xiaofeng Chen, Yulong Mu, Jing Ai

J Mol Med (Berl)· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis